Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147808 · ClinicalTrials.gov registry record · Phase 1
A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects
A Phase 1 study, sponsored by Lexicon Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT02147808 is a Phase 1 study that has completed, run by Lexicon Pharmaceuticals. The registered enrollment target is 24 participants.
The verdict
NCT02147808, a Phase 1 study, has completed, sponsored by Lexicon Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study is designed to evaluate the effects of telotristat ethyl on the pharmacokinetics of midazolam in healthy male and female subjects.
Interventions
- DRUG Midazolam
- DRUG Telotristat etiprate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02147808
The ClinicalTrials.gov registry entry for NCT02147808 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lexicon Pharmaceuticals, which has 56 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midazolam is the first listed.
NCT02147808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02147808 about?
NCT02147808 is a clinical study titled "A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects". This study is designed to evaluate the effects of telotristat ethyl on the pharmacokinetics of midazolam in healthy male and female subjects.
What is the current status of trial NCT02147808?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2014-05.
What interventions are being tested in trial NCT02147808?
The interventions under investigation include: Midazolam (DRUG), Telotristat etiprate (DRUG).
Who is sponsoring clinical trial NCT02147808?
This trial is sponsored by Lexicon Pharmaceuticals, which has 56 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.